These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 31735010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.
    Marano AL, Clarke JM, Morse MA, Shah A, Barrow W, Selim MA, Hall RP, Cardones AR.
    Br J Dermatol; 2019 Sep; 181(3):580-583. PubMed ID: 30244487
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Checkpoint Inhibitor-Associated Hypophysitis.
    Chang LS, Yialamas MA.
    J Gen Intern Med; 2018 Jan; 33(1):125-127. PubMed ID: 28770379
    [No Abstract] [Full Text] [Related]

  • 9. Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy.
    Tan I, Malinzak M, Salama AKS.
    J Immunother Cancer; 2018 Jul 31; 6(1):77. PubMed ID: 30064495
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Skin Reactions to Immune Checkpoint Inhibitors.
    Patel AB, Pacha O.
    Adv Exp Med Biol; 2020 Jul 31; 1244():235-246. PubMed ID: 32301018
    [Abstract] [Full Text] [Related]

  • 12. Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy.
    Kersh AE, Schuchter LM, Elenitsas R, Chu EY.
    Immunotherapy; 2020 Sep 31; 12(13):951-956. PubMed ID: 32772616
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety of Combination Immune Checkpoint Inhibitors Compared to Monotherapy; A Systematic Review and Meta-Analysis.
    Abdelhafeez AAM, Shohdy KS, Ibrahim W.
    Cancer Invest; 2020 Mar 31; 38(3):150-157. PubMed ID: 31977260
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Subacute cutaneous lupus erythematosus induced by nivolumab.
    Liu RC, Sebaratnam DF, Jackett L, Kao S, Lowe PM.
    Australas J Dermatol; 2018 May 31; 59(2):e152-e154. PubMed ID: 28726325
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.